EPB227 | Acceptability and uptake of self-sampling for etiological diagnosis of sexually transmitted infections (STIs) among transgender women in Brazil | E-poster | Clinical issues in transgender people |
PEMOB35 | Addressing sexual health in trans masculinities: lessons learned from TransCITAR transgender cohort study in Argentina | Poster exhibition | Clinical issues in transgender people |
EPB267 | Both typical and atypical radiological changes predict poor COVID-19 outcome in HIV-positive patients from a multinational observational study - data from Euroguidelines in Central and Eastern Europe Network Group | E-poster | Clinical manifestations and features of COVID-19 and HIV co-infection |
EPB268 | Vaccination impact on COVID-19 related hospitalizations among PLWHIV in Argentina | E-poster | Clinical manifestations and features of COVID-19 and HIV co-infection |
EPB269 | Humoral immune response to COVID-19 vaccination in HIV infected adults with and without prior COVID: comparison with HIV uninfected controls | E-poster | Clinical manifestations and features of COVID-19 and HIV co-infection |
EPB270 | Body composition and SARS-CoV-2 antibody levels among underserved populations in Miami, Florida: a rapid acceleration of diagnostics-underserved populations (RADxUP) study | E-poster | Clinical manifestations and features of COVID-19 and HIV co-infection |
EPB271 | Decay pattern of anti'SARS-CoV-2 antibodies in people with HIV | E-poster | Clinical manifestations and features of COVID-19 and HIV co-infection |
OAB0404 | Are people living with HIV at higher risk of severe and fatal COVID-19? | Oral abstract session with live Q&A | Clinical manifestations and features of COVID-19 and HIV co-infection |
EPC297 | I=I (U=U) is good news | E-poster | Combination prevention strategies |
EPC298 | Accelerated declines in HIV incidence and flattening prevalence trends with scale-up of combination HIV prevention in a Ugandan adult population cohort, 1989-2021 | E-poster | Combination prevention strategies |